{
    "organizations": [],
    "uuid": "5bf3bef14d739cd52faed165a8efe677fb0058e9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-gets-anda/brief-glenmark-pharmaceuticals-gets-anda-approval-for-clobetasol-propionate-topical-solution-usp-idUSFWN1RW0ZG",
    "ord_in_thread": 0,
    "title": "BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Clobetasol Propionate Topical Solution USP",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* GETS ANDA APPROVAL FOR CLOBETASOL PROPIONATE TOPICAL SOLUTION USP\n* SAYS PRODUCT WILL BE MANUFACTURED AT CO'S BADDI PLANT IN INDIA Source text - bit.ly/2F0WQol Further company coverage:\n ",
    "published": "2018-04-20T11:13:00.000+03:00",
    "crawled": "2018-04-20T11:32:23.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "glenmark",
        "pharmaceutical",
        "ltd",
        "get",
        "anda",
        "approval",
        "clobetasol",
        "propionate",
        "topical",
        "solution",
        "usp",
        "say",
        "product",
        "manufactured",
        "co",
        "baddi",
        "plant",
        "india",
        "source",
        "text",
        "company",
        "coverage"
    ]
}